Medicine guide

ACT BORTEZOMIB

As listed in the register: ACT BORTEZOMIB

3.5 mg · powder for solution

  • Prescription only
  • Cancer treatments and immune-system medicines
Made by
Teva Canada Limited

Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.

What it is for

Medicine groupCancer treatments and immune-system medicinesL01XG01

Mediclarum has not yet retrieved and stored the official label for this product, so none of its text is shown here. Open the official leaflet

Same active substance, strength and form in other countries

Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.

Medicine passport: one printable page to show a pharmacist abroad

BulgariaNo exact match for this strength and form

European UnionNo exact match for this strength and form

SpainNo exact match for this strength and form

NetherlandsNo exact match for this strength and form

SwitzerlandNo exact match for this strength and form

Details

Made byTeva Canada Limited
Active substanceBortezomib (Bortezomib Mannitol Boronic Ester)
Used inCancer treatments and immune-system medicines
Strength3.5 mg
Formpowder for solution
ClassificationL01XG01 · Cancer treatments and immune-system medicines
Routesubcutaneous, intravenous
Dispensing (as stated by the register)PRESCRIPTION
StatusMarketed
MarketedYes, according to the register
DIN02438399
DPD drug code92278

Source: Drug Product Database · 2026-09-30 · not reviewed by a clinician

Contains information licensed under the Open Government Licence – Canada. Reuse terms: Open Government Licence – Canada.

Same active substance

These contain the same substance. That does not mean one can replace another — ask a pharmacist.